As of April 2024 Dermapharm has a market cap of $1.81 Billion. This makes Dermapharm the world's 4187th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.81 B | -28.13% |
2023 | $2.51 B | 15.17% |
2022 | $2.18 B | -59.74% |
2021 | $5.43 B | 43.15% |
2020 | $3.79 B | 56.84% |
2019 | $2.41 B | 75.23% |
2018 | $1.38 B |
On Apr 18th, 2024 the market cap of Dermapharm was reported to be: